Dana Cialla-May

Dr. Dana Cialla-May serves as a Group Leader in the Research Department of Spectroscopy/Imaging at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany, where she heads the Working Group for Plasmon-Enhanced Bioanalytics. Her research program focuses on developing advanced spectroscopic and biosensing technologies for biomedical applications, with particular expertise in Surface-Enhanced Raman Spectroscopy (SERS) and aptamer-based detection systems.

Dr. Cialla-May's research spans multiple critical areas of biomedical diagnostics. She specializes in creating plasmon-enhanced bioanalytical methods for point-of-care diagnostic applications, integrating spectroscopic techniques with microfluidic systems to develop novel platforms for drug monitoring, toxin detection, and disease diagnosis. Her work addresses fundamental challenges in SERS technology, particularly regarding reproducibility and stability in complex biological matrices such as blood plasma, tissues, and environmental samples. She has made significant contributions to both the theoretical understanding and practical implementation of these technologies.

Analysis of her recent publication trends reveals a cohesive research trajectory focused on multiplexed detection systems for diverse analytes including antibiotics, chemotherapeutic drugs, venoms, and marine biotoxins. Her work demonstrates expertise in both direct and indirect SERS approaches, electrochemical aptasensing techniques, and microphysiological modeling. The consistent publication in high-impact journals across chemistry, biomedical engineering, and analytical science reflects the interdisciplinary nature and significance of her contributions to advancing diagnostic technologies from bench to bedside.